Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07288567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

StatusRecruiting
PhasePhase 3
Started2026-01-29
View on ClinicalTrials.gov ↗

Amendment history

2026-09-03
Study Status, Contacts/Locations v11
Study sites39→38
2026-08-12
Study Status, Contacts/Locations v10
Study sites39 entries, revised
LocalProscience InstitutionResearch - 0024Group Local Institution - 00830122 LocalBoston InstitutionChildren's -Hospital Cabinet 0076 LocalMedical InstitutionIndividual -Dr 0042Gheorghita Karina Lidia
2026-07-17
Study Status, Contacts/Locations v9
Trial sites reduced: 44 → 39 locations
2026-07-14
Study Status, Contacts/Locations v8
Study sites44 entries, revised
LocalVAST InstitutionClinical -Research Cluj 0046Napoca Emergency Hospital for Children, Department of Pediatric Psychiatry LocalEmergency InstitutionClinical -Hospital 0031 LocalFor InstitutionChildren -Louis 0038Turcanu Timis
2026-06-29
Study Status, Contacts/Locations v7
Trial sites expanded: 41 → 44 locations
Show 6 earlier versions
2026-06-01
Study Status, Contacts/Locations v6
Study sites43→41
2026-05-08
Study Status, Contacts/Locations v5
Study sites44→43
2026-04-06
Study Status, Contacts/Locations v4
Study sites45→44
2026-02-20
Study Identification, Study Status, Contacts/Locations v3
Study sites43→45
Study title+16 characters
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
2026-02-03
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations, IPDSharing, References v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2026-01-27→confirmed 2026-01-29
Study sites38→43
2026-01-02
Study Status, Contacts/Locations v1
Study sites35→38
2025-12-16
Original filing
The purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.
Trial Details
NCT Number NCT07288567
Lead Sponsor Bristol-Myers Squibb
Conditions Schizophrenia
Enrollment 166 participants
Start Date 2026-01-29
Primary Completion 2029-12-18 (estimated)
Study Completion 2029-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-09-04